443 related articles for article (PubMed ID: 12220549)
1. IL-6 in autoimmune disease and chronic inflammatory proliferative disease.
Ishihara K; Hirano T
Cytokine Growth Factor Rev; 2002; 13(4-5):357-68. PubMed ID: 12220549
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and its relation to inflammation and disease.
Hirano T
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
Nishimoto N
Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
[TBL] [Abstract][Full Text] [Related]
4. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
[TBL] [Abstract][Full Text] [Related]
5. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
[TBL] [Abstract][Full Text] [Related]
6. IL-6 positively regulates Foxp3+CD8+ T cells in vivo.
Nakagawa T; Tsuruoka M; Ogura H; Okuyama Y; Arima Y; Hirano T; Murakami M
Int Immunol; 2010 Feb; 22(2):129-39. PubMed ID: 20042455
[TBL] [Abstract][Full Text] [Related]
7. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
8. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
Beebe AM; Cua DJ; de Waal Malefyt R
Cytokine Growth Factor Rev; 2002; 13(4-5):403-12. PubMed ID: 12220553
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir.
Hirano T
Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(7):717-30. PubMed ID: 20689230
[TBL] [Abstract][Full Text] [Related]
10. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Akira S; Kishimoto T
Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
[TBL] [Abstract][Full Text] [Related]
11. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.
Zhang GX; Gran B; Yu S; Li J; Siglienti I; Chen X; Kamoun M; Rostami A
J Immunol; 2003 Feb; 170(4):2153-60. PubMed ID: 12574388
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 in autoimmune disorders.
Yoshizaki K; Kuritani T; Kishimoto T
Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal gp130 signaling and autoimmune disease].
Ishihara K; Atsumi T
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2336-42. PubMed ID: 12518458
[No Abstract] [Full Text] [Related]
14. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
15. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation.
Yang Y; Ochando J; Yopp A; Bromberg JS; Ding Y
J Immunol; 2005 Mar; 174(5):2720-9. PubMed ID: 15728480
[TBL] [Abstract][Full Text] [Related]
16. Regulatory B cells in autoimmune diseases: how do they work?
Lemoine S; Morva A; Youinou P; Jamin C
Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
[TBL] [Abstract][Full Text] [Related]
17. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.
Kollias G; Kontoyiannis D
Cytokine Growth Factor Rev; 2002; 13(4-5):315-21. PubMed ID: 12220546
[TBL] [Abstract][Full Text] [Related]
18. Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3.
Zhao L; Melenhorst JJ; Hennighausen L
Mol Endocrinol; 2002 Dec; 16(12):2902-12. PubMed ID: 12456808
[TBL] [Abstract][Full Text] [Related]
19. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
[TBL] [Abstract][Full Text] [Related]
20. Absence of interleukin-17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis.
Corneth OB; Mus AM; Asmawidjaja PS; Klein Wolterink RG; van Nimwegen M; Brem MD; Hofman Y; Hendriks RW; Lubberts E
Arthritis Rheumatol; 2014 Feb; 66(2):340-9. PubMed ID: 24504806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
